2-98093151-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_144992.5(VWA3B):c.59G>T(p.Gly20Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_144992.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWA3B | NM_144992.5 | c.59G>T | p.Gly20Val | missense_variant | 2/28 | ENST00000477737.6 | NP_659429.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWA3B | ENST00000477737.6 | c.59G>T | p.Gly20Val | missense_variant | 2/28 | 1 | NM_144992.5 | ENSP00000417955.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152106Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249534Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135380
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461878Hom.: 0 Cov.: 30 AF XY: 0.0000316 AC XY: 23AN XY: 727242
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152106Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2024 | The c.59G>T (p.G20V) alteration is located in exon 2 (coding exon 1) of the VWA3B gene. This alteration results from a G to T substitution at nucleotide position 59, causing the glycine (G) at amino acid position 20 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at